Mutya Harsch is CHIEF LEGAL OFFICER AND GC of VYNE Therapeutics Inc.. Currently has a direct ownership of 136,646 shares of VYNE, which is worth approximately $144,844. The most recent transaction as insider was on Dec 31, 2020, when has been sold 1,822 shares (Common Stock) at a price of $1.58 per share, resulting in proceeds of $2,879. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
5.32% 3M change
8.46% 12M change
Total Value Held $144,844

Mutya Harsch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
SELL
Payment of exercise price or tax liability
$2,879 $1.58 p/Share
1,822 Reduced 0.56%
325,703 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$15,167 $1.45 p/Share
10,460 Added 3.09%
327,525 Common Stock
Sep 30 2020
SELL
Payment of exercise price or tax liability
$3,025 $1.66 p/Share
1,822 Reduced 0.57%
317,065 Common Stock

Also insider at

STSA
Satsuma Pharmaceuticals, Inc. Healthcare
MH

Mutya Harsch

CHIEF LEGAL OFFICER AND GC
Bridgewater, NJ

Track Institutional and Insider Activities on VYNE

Follow VYNE Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNE shares.

Notify only if

Insider Trading

Get notified when an Vyne Therapeutics Inc. insider buys or sells VYNE shares.

Notify only if

News

Receive news related to VYNE Therapeutics Inc.

Track Activities on VYNE